Traws Pharma, Inc.
TRAW
$0.83
-$0.01-0.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.11M | -7.44M | -3.96M | -915.00K | 21.49M |
| Total Depreciation and Amortization | 44.00K | 44.00K | 15.00K | 1.00K | 1.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 793.00K | 416.00K | 138.00K | -41.00K | -26.35M |
| Change in Net Operating Assets | 3.69M | 4.23M | -202.00K | -5.02M | -576.00K |
| Cash from Operations | -2.58M | -2.76M | -4.01M | -5.98M | -5.44M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | -2.59M | -- | -- |
| Cash from Investing | -- | 0.00 | -2.59M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.90M | 2.10M | 116.00K | 3.26M | 136.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.94M | -178.00K | -164.00K | -123.00K |
| Cash from Financing | 1.90M | 158.00K | -62.00K | 3.10M | 13.00K |
| Foreign Exchange rate Adjustments | -8.00K | 0.00 | -3.00K | 28.00K | 23.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -687.00K | -2.60M | -6.66M | -2.86M | -5.40M |